Analysis of the evolution of the price of oncology drugs after the loss of their patent and the marketing of generic medicines

BACKGROUND AND RESEARCH QUESTION: Loss of exclusivity of oncology drugs causes an important drop in their price due to the marketing of generic medicines. In this article we study how the price of certain oncology drugs evolves throughout time after the loss of their patent, both in terms of the not...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Sesmero, José M., Smith, Borja, Madurga, Julen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768611/
https://www.ncbi.nlm.nih.gov/pubmed/36628314
http://dx.doi.org/10.33393/grhta.2022.2366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768611/
https://www.ncbi.nlm.nih.gov/pubmed/36628314
http://dx.doi.org/10.33393/grhta.2022.2366

Ejemplares similares